Advani RH - Search Results

1

Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).

Ganjoo K, Hong F, Horning SJ, Gascoyne RD, Natkunam Y, Swinnen LJ, Habermann TM, Kahl BS, Advani RH. Ganjoo K, et al. Among authors: advani rh. Leuk Lymphoma. 2014 Apr;55(4):768-72. doi: 10.3109/10428194.2013.816700. Epub 2013 Jul 29. Leuk Lymphoma. 2014. PMID: 23786456 Free PMC article.

2

Granulocyte-macrophage colony-stimulating factor (GM-CSF) as an adjunct to autologous hemopoietic stem cell transplantation for lymphoma.

Advani R, Chao NJ, Horning SJ, Blume KG, Ahn DK, Lamborn KR, Fleming NC, Bonnem EM, Greenberg PL. Advani R, et al. Ann Intern Med. 1992 Feb 1;116(3):183-9. doi: 10.7326/0003-4819-116-3-183. Ann Intern Med. 1992. PMID: 1345803 Clinical Trial.

3

Epstein-Barr virus-associated lymphoproliferative disorder following autologous bone marrow transplantation for non-Hodgkin's lymphoma.

Chao NJ, Berry GJ, Advani R, Horning SJ, Weiss LM, Blume KG. Chao NJ, et al. Transplantation. 1993 Jun;55(6):1425-8. Transplantation. 1993. PMID: 8390736 No abstract available.

4

Treatment of angioimmunoblastic T-cell lymphoma with cyclosporine.

Advani R, Warnke R, Sikic BI, Horning S. Advani R, et al. Ann Oncol. 1997 Jun;8(6):601-3. doi: 10.1023/a:1008275208592. Ann Oncol. 1997. PMID: 9261530 Free article. No abstract available.

5

Treatment of early-stage Hodgkin's disease.

Advani RH, Horning SJ. Advani RH, et al. Semin Hematol. 1999 Jul;36(3):270-81. Semin Hematol. 1999. PMID: 10462327 Review.

6

Treatment of multicentric Castleman's disease complicated by the development of non-Hodgkin's lymphoma with high-dose chemotherapy and autologous peripheral stem-cell support.

Advani R, Warnke R, Rosenberg S. Advani R, et al. Ann Oncol. 1999 Oct;10(10):1207-9. doi: 10.1023/a:1008366721816. Ann Oncol. 1999. PMID: 10586338 Free article.

7

A phase I trial of doxorubicin, paclitaxel, and valspodar (PSC 833), a modulator of multidrug resistance.

Advani R, Fisher GA, Lum BL, Hausdorff J, Halsey J, Litchman M, Sikic BI. Advani R, et al. Clin Cancer Res. 2001 May;7(5):1221-9. Clin Cancer Res. 2001. PMID: 11350887 Clinical Trial.

8

Stage I and II follicular non-Hodgkin's lymphoma: long-term follow-up of no initial therapy.

Advani R, Rosenberg SA, Horning SJ. Advani R, et al. J Clin Oncol. 2004 Apr 15;22(8):1454-9. doi: 10.1200/JCO.2004.10.086. Epub 2004 Mar 15. J Clin Oncol. 2004. PMID: 15024027

9

Management of advanced stage Hodgkin lymphoma.

Advani R, Ai WZ, Horning SJ. Advani R, et al. J Natl Compr Canc Netw. 2006 Mar;4(3):241-7. doi: 10.6004/jnccn.2006.0023. J Natl Compr Canc Netw. 2006. PMID: 16507271 Review.

10

Angioimmunoblastic T cell lymphoma: treatment experience with cyclosporine.

Advani R, Horwitz S, Zelenetz A, Horning SJ. Advani R, et al. Leuk Lymphoma. 2007 Mar;48(3):521-5. doi: 10.1080/10428190601137658. Leuk Lymphoma. 2007. PMID: 17454592

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

313 results

Search Page

Filters